Formats
  1. Journal Article (66975)
  2. Meeting Abstract (33621)
  3. Book Section (5116)
  4. Review (3781)
  5. Editorial (2185)
  6. Conference Paper (1531)
  7. Correspondence (669)
  8. Guidelines (666)
  9. Research Letter (554)
  10. Book Whole (345)
  11. Miscellaneous (340)
Groups
  1. Department of Medicine (39123)
  2. GSK Faculty (22500)
  3. Solid Tumor Oncology Division (22113)
  4. Surgery (21304)
  5. Survivorship Research (15795)
  6. Sloan Kettering Institute Faculty (15665)

More Groups

People
  1. Marc Ladanyi (1328)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1053)

More People

Years
  1. 2026 (1)
  2. 2025 (2315)
  3. 2024 (5382)
  4. 2023 (5808)
  5. 2022 (6169)
  6. 2021 (5720)

More Years

Publications
  1. Journal of Clinical Oncology (8596)
  2. Blood (4954)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2614)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1814)

More Publications

Publishers
  1. Elsevier Inc. (13867)
  2. American Society of Clinical Oncology (9180)
  3. Springer (7199)
  4. Nature Publishing Group (6392)
  5. American Association for Cancer Research (6014)
  6. Elsevier Science, Inc. (5526)

More Publishers

Results (115783)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors
    Meeting Abstract

    Bedard, P. L.; Hernando-Calvo, A.; Carvajal, R. D.; Morris, V. K.; Paik, P. K.; Zandberg, D. P.; Kaczmar, J. M.; Niculescu, L.; Bohr, D.; Reiners, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • COVID-19 in patients with gynecologic cancer: A preliminary report from the COVID-19 and Cancer Consortium (CCC19)
    Meeting Abstract

    Beeghly-Fadiel, A.; Prescott, L. S.; Ruiz-Garcia, E.; Hwang, C.; Heilman, H.; McKay, R. R.; Saliby, R. M.; Lau, S.; Nagaraj, G.; Puc, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A randomized trial on pelvic lymph node dissection versus no lymph node dissection at radical prostatectomy: Report of a trial in progress
    Meeting Abstract

    Benfante, N.; Carroll, E.; Carruthers, J.; Donahue, T. F.; Eastham, J. A.; Ehdaie, B.; Goh, A. C.; Laudone, V. P.; Pietzak, E. J.; Smith, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Patient preferences for second-line treatment options in diffuse large B-cell lymphoma: A discrete choice experiment
    Meeting Abstract

    Birch, K.; Chiu, K.; Baumgardner, J.; Snider, J.; Wade, S. W.; Shah, G. L.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • ROCC/GOG-3043: A randomized non-inferiority trial of robotic versus open radical hysterectomy for early-stage cervical cancer
    Meeting Abstract

    Bixel, K. L.; Leitao, M. M.; Chase, D. M.; Quick, A.; Lim, P. C.; Eskander, R. N.; Gotlieb, W. H.; LoCoco, S.; Martino, M. A.; McCormick, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of casein kinase 1α and cyclin dependent kinase 7/9 inhibition in patients with relapsed or refractory AML: A first-in-human study of BTX-A51
    Meeting Abstract

    Ball, B.; Borthakur, G.; Stein, A. S.; Chan, K.; Thai, D. L.; Stein, E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of VS-6766 (RAF/MEK clamp) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC)
    Meeting Abstract

    Banerjee, S. N.; Monk, B. J.; Van Nieuwenhuysen, E.; Moore, K. N.; Oaknin, A.; Fabbro, M.; Colombo, N.; O'Malley, D. M.; Coleman, R. L.; Oza, A. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Genomic alterations and evolution in patients with prostate cancer with histologic evidence of neuroendocrine differentiation
    Meeting Abstract

    Barnett, E.; Carbone, E.; Keegan, N. M.; Vasselman, S. E.; Nweji, B.; Zaidi, S.; Scher, H. I.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Updated interim analysis of the randomized phase 1b/3 study of tazemetostat in combination with lenalidomide and rituximab in patients with relapsed/refractory follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; Park, S. I.; Phillips, T. J.; Amengual, J.; Andorsky, D. J.; Campbell, P.; McKay, P.; Leonard, J. P.; Sondhi, M.; Yang, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1b/2 study of batiraxcept (AVB-S6-500) in combination with cabozantinib, cabozantinib and nivolumab, and as monotherapy in patients with advanced or metastatic clear cell renal cell carcinoma (NCT04300140)
    Meeting Abstract

    Beckermann, K.; Shah, N. J.; Vogelzang, N. J.; Mao, S. S.; Ornstein, M. C.; Hammers, H. J.; Gao, X.; McDermott, D. F.; Haas, N. B.; Yan, H. X.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save